While we did not detect genomic alterations involving MMR or Polε/Polδ to explain this patient’s ultra-hypermutated cancer, we did detect a truncal amplification of a region on chromosome 22q containing genes encoding the APOBEC3A-H (or A3 subfamily) cytidine deaminases. This evidence concerns the gene POLD1 and cancer.